JP2022506761A5 - - Google Patents
Info
- Publication number
- JP2022506761A5 JP2022506761A5 JP2021524345A JP2021524345A JP2022506761A5 JP 2022506761 A5 JP2022506761 A5 JP 2022506761A5 JP 2021524345 A JP2021524345 A JP 2021524345A JP 2021524345 A JP2021524345 A JP 2021524345A JP 2022506761 A5 JP2022506761 A5 JP 2022506761A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody construct
- item
- seq
- heavy chain
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024144789A JP2024170456A (ja) | 2018-10-29 | 2024-08-26 | IgA抗体構築物を含む組成物および方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18203183 | 2018-10-29 | ||
| EP18203183.1 | 2018-10-29 | ||
| US201862752641P | 2018-10-30 | 2018-10-30 | |
| US62/752,641 | 2018-10-30 | ||
| PCT/US2019/058648 WO2020092427A1 (en) | 2018-10-29 | 2019-10-29 | COMPOSITIONS AND METHODS COMPRISING IgA ANTIBODY CONSTRUCTS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024144789A Division JP2024170456A (ja) | 2018-10-29 | 2024-08-26 | IgA抗体構築物を含む組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022506761A JP2022506761A (ja) | 2022-01-17 |
| JP2022506761A5 true JP2022506761A5 (cg-RX-API-DMAC7.html) | 2022-10-31 |
Family
ID=70462698
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524345A Pending JP2022506761A (ja) | 2018-10-29 | 2019-10-29 | IgA抗体構築物を含む組成物および方法 |
| JP2024144789A Pending JP2024170456A (ja) | 2018-10-29 | 2024-08-26 | IgA抗体構築物を含む組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024144789A Pending JP2024170456A (ja) | 2018-10-29 | 2024-08-26 | IgA抗体構築物を含む組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210332131A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3873942A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022506761A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210096612A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113260632A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019369397B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3118312A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2596411B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020092427A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3131705A1 (en) * | 2019-03-27 | 2020-10-01 | Umc Utrecht Holding B.V. | Engineered iga antibodies and methods of use |
| CA3187850A1 (en) | 2020-08-04 | 2022-02-10 | Bryan Glaser | Pd-l1 binding agents and uses thereof |
| JP2023546679A (ja) * | 2020-10-22 | 2023-11-07 | アクティニウム ファーマシューティカルズ インコーポレイテッド | がん治療における放射免疫療法とcd47遮断の併用 |
| CN116829698A (zh) * | 2020-12-07 | 2023-09-29 | 加利福尼亚大学董事会 | 通过SIRP-α衔接体的先天免疫细胞沉默 |
| CN116731161A (zh) * | 2021-09-18 | 2023-09-12 | 南开大学 | 工程化IgG和IgA嵌合的“四叶草型X抗体” |
| EP4475886A4 (en) * | 2022-02-09 | 2026-03-18 | Exelixis Inc | MULTI-SPECIFIC LIAISON AGENTS AND THEIR USES |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0226878D0 (en) * | 2002-11-18 | 2002-12-24 | Univ Warwick | Antibodies |
| HUE038955T2 (hu) * | 2003-11-05 | 2018-12-28 | Roche Glycart Ag | Antigén-kötõ molekulák fokozott Fc receptor-kötõ affinitással és effektor funkcióval |
| US20090215992A1 (en) * | 2005-08-19 | 2009-08-27 | Chengbin Wu | Dual variable domain immunoglobulin and uses thereof |
| US10407513B2 (en) * | 2008-09-26 | 2019-09-10 | Ucb Biopharma Sprl | Biological products |
| SI2477648T1 (sl) * | 2009-09-15 | 2022-09-30 | The Board Of Trustees Of The Leland Stanford Junior University | Sinergijska terapija proti CD47 za krvne rake |
| WO2013087914A1 (en) * | 2011-12-16 | 2013-06-20 | Synthon Biopharmaceuticals B.V. | EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
| RU2693078C2 (ru) * | 2012-12-03 | 2019-07-01 | Новиммун С.А. | Анти-cd47 антитела и способы их применения |
| US20140213771A1 (en) * | 2012-12-28 | 2014-07-31 | Abbvie, Inc. | Multi-specific binding proteins |
| EP2970485A1 (en) * | 2013-03-15 | 2016-01-20 | Merck Patent GmbH | Tetravalent bispecific antibodies |
| AU2014374055B2 (en) * | 2013-12-30 | 2018-11-08 | Epimab Biotherapeutics Inc. | Fabs-in-tandem immunoglobulin and uses thereof |
| EP3188758B1 (en) * | 2014-08-08 | 2023-10-04 | The Board of Trustees of the Leland Stanford Junior University | Sirp alpha-antibody fusion proteins |
| ES2751915T5 (es) * | 2014-08-15 | 2022-12-23 | Merck Patent Gmbh | Proteínas de fusión de inmunoglobulina con SIRP alfa |
| US9650441B2 (en) * | 2015-09-21 | 2017-05-16 | Erasmus University Medical Center | Anti-CD47 antibodies and methods of use |
| CN107459579B (zh) * | 2016-06-01 | 2021-09-24 | 泰州迈博太科药业有限公司 | 一种靶向egfr和cd47双特异性融合蛋白、制备方法及应用 |
| CA3035427A1 (en) * | 2016-09-01 | 2018-03-08 | Umc Utrecht Holding B.V. | Cd20 antibodies |
| KR102607101B1 (ko) * | 2017-01-26 | 2023-11-29 | 제트엘아이피 홀딩 리미티드 | Cd47 항원 결합 유닛 및 그것의 사용 |
| WO2019022600A1 (en) * | 2017-07-24 | 2019-01-31 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | TREATMENT OF PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPA INTERACTION - CD47 |
| AU2018314765C1 (en) * | 2017-08-08 | 2025-11-20 | Bruker Spatial Biology, Inc. | Obinutuzumab treatment of a DLBCL patient subgroup |
-
2019
- 2019-10-29 GB GB2107478.6A patent/GB2596411B/en active Active
- 2019-10-29 EP EP19879444.8A patent/EP3873942A4/en active Pending
- 2019-10-29 AU AU2019369397A patent/AU2019369397B2/en active Active
- 2019-10-29 CN CN201980087109.4A patent/CN113260632A/zh active Pending
- 2019-10-29 JP JP2021524345A patent/JP2022506761A/ja active Pending
- 2019-10-29 WO PCT/US2019/058648 patent/WO2020092427A1/en not_active Ceased
- 2019-10-29 CA CA3118312A patent/CA3118312A1/en active Pending
- 2019-10-29 KR KR1020217016137A patent/KR20210096612A/ko not_active Ceased
-
2021
- 2021-04-28 US US17/242,793 patent/US20210332131A1/en active Pending
-
2024
- 2024-08-26 JP JP2024144789A patent/JP2024170456A/ja active Pending